Accueil >
Publications >
A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients

A PK/PD study of Delta-4 abiraterone metabolite in metastatic castration-resistant prostate cancer patients

1 oct. 2018Pharmacological Research

DOI : 10.1016/j.phrs.2018.08.016

Auteurs

Benoit Blanchet, Edith Carton, Mohammad Alyamani, Lisa Golmard, Olivier Huillard, Audrey Thomas-Scheomann, Michel Vidal, François Goldwasser, Nima Sharifi, Jérôme Alexandre